# Tango Therapeutics, Inc.: Form 8-K, filed Nov 21, 2025

- Company: [Tango Therapeutics, Inc.](/companies/tngx.md) (CIK 1819133)
- Form: 8-K
- Filed: 2025-11-21
- Accepted by EDGAR: Nov 21, 2025, 08:36 ET
- Period: 2025-11-18
- Accession: 0001193125-25-290679
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1819133/000119312525290679/d921087d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1819133/000119312525290679/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 1.02: Termination of a material agreement

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1819133/000119312525290679/d921087d8k.htm

Filed Nov 21, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-290679. Last ingested by Listed: Nov 9, 2026, 17:30 ET. No prices; not investment advice.